X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
index medicus (7) 7
female (6) 6
male (6) 6
aged (5) 5
hepatocellular carcinoma (5) 5
middle aged (5) 5
liver cancer (4) 4
patients (4) 4
positron emission tomography (4) 4
adult (3) 3
brain (3) 3
lewy body disease (3) 3
neoplasm staging (3) 3
nuclear medicine (3) 3
oncology (3) 3
pet/ct (3) 3
tomography (3) 3
treatment outcome (3) 3
tumors (3) 3
aluminum hydroxide (2) 2
brain - diagnostic imaging (2) 2
brain imaging (2) 2
cancer therapies (2) 2
cardiology (2) 2
care and treatment (2) 2
cerebellum (2) 2
chronic fatigue syndrome (2) 2
cognitive ability (2) 2
computed tomography (2) 2
contrast-enhanced ct (2) 2
diagnosis (2) 2
disease (2) 2
fasciitis - diagnostic imaging (2) 2
fatigue (2) 2
fluorodeoxyglucose f18 (2) 2
gastroenterology & hepatology (2) 2
hepatoma (2) 2
imaging / radiology (2) 2
liver transplantation (2) 2
low-dose pet/ct (2) 2
lymphoma (2) 2
medicine & public health (2) 2
mesh terms (2) 2
metabolism (2) 2
mibg (2) 2
myositis - diagnostic imaging (2) 2
neurology (2) 2
patient management (2) 2
pet imaging (2) 2
positron-emission tomography (2) 2
positron-emission tomography - methods (2) 2
radiation exposure (2) 2
radiopharmaceuticals (2) 2
reproducibility of results (2) 2
research article (2) 2
sensitivity and specificity (2) 2
123 i-fp-cit (1) 1
123i-fp-cit (1) 1
18 f-fdg (1) 1
18 f-florbetaben (1) 1
18f-fdg (1) 1
18f-florbetaben (1) 1
[18f]-naf (1) 1
a-fetoprotein (1) 1
ablation techniques - methods (1) 1
abnormalities (1) 1
abridged index medicus (1) 1
accuracy (1) 1
administration, oral (1) 1
adolescent (1) 1
allografts (1) 1
alpha (1) 1
alpha fetoproteins (1) 1
alpha-fetoproteins - analysis (1) 1
aluminum (1) 1
alzheimer's disease (1) 1
alzheimers-disease (1) 1
amyloidosis (1) 1
amyloidosis - diagnostic imaging (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antipsychotic drugs (1) 1
apc (1) 1
batteries (1) 1
bclc classification (1) 1
bioindicators (1) 1
biomarkers (1) 1
biopsy (1) 1
blacks (1) 1
blacks in literature (1) 1
blacks in the performing arts (1) 1
blood-brain barrier (1) 1
brachytherapy - methods (1) 1
brain - metabolism (1) 1
brain - physiopathology (1) 1
brain damage (1) 1
brain diseases, metabolic - diagnostic imaging (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Vilgrain, Valérie and Pereira, Helena and Assenat, Eric and Guiu, Boris and Ilonca, Alina Diana and Ilonca, Alina D and Pageaux, Georges-Philippe and Sibert, Annie and Bouattour, Mohamed and Lebtahi, Rachida and Allaham, Wassim and Barraud, Hélène and Laurent, Valérie and Mathias, Elodie and Bronowicki, Jean-Pierre and Tasu, Jean-Pierre and Perdrisot, Rémy and Silvain, Christine and Gerolami, René and Mundler, Olivier and Seitz, Jean-Francois and Vidal, Vincent and Aubé, Christophe and Oberti, Frédéric and Couturier, Olivier and Brenot-Rossi, Isabelle and Raoul, Jean-Luc and Sarran, Anthony and Costentin, Charlotte and Itti, Emmanuel and Luciani, Alain and Adam, René and Lewin, Maïté and Samuel, Didier and Ronot, Maxime and Dinut, Aurelia and Castera, Laurent and Chatellier, Gilles and Delhom - Christol, Elisabeth and Lonjon, Julie and Abdel-Rehim, Mohamed and Dieudonné, Arnaud and Bazin, Christophe and Chagneau-Derrode, Carine and Borentain, Patrick and Bouvier, Antoine and Vervueren, Laurent and Chalaye, Julia and Kobeiter, Hicham and Edeline, Julien and Garin, Etienne and Rolland, Yan and Archambeaud, Isabelle and Eugene, Thomas and Frampas, Eric and Cassinotto, Christophe and Guyot, Martine and Hiriart, Jean-Baptiste and Lapuyade, Bruno and Vergniol, Julien and Bachellier, Philippe and Detour, Julien and Duclos, Bernard and Greget, Michel and Habersetzer, Francois and Imperiale, Alessio and Merle, Philippe and Rode, Agnès and Morvan, Julie and Nguyen-Khac, Eric and Yzet, Thierry and Baudin, Guillaume and Chevallier, Patrick and Mahamat, Abakar and Piche, Thierry and Razzouk, Micheline and Hillon, Patrick and Loffroy, Romaric and Toubeau, Michel and Vincent, Julie and Barabino, Gabriele and Bouarioua, Nadia and Cuilleron, Muriel and Ecochard, Marie and Prevot-Bitot, Nathalie and Leroy, Vincent and Roux, Julie and Sengel, Christian and Bourcier, Valérie and Ganne-Carrie, Nathalie and Seror, Olivier and Costo, Sylvie and Dao, Thông and Pelage, Jean-Pierre and Dumortier, Jérôme and Giammarile, Francesco and Valette, Pierre-Jean and Ghazzar, Nadia and Pellerin, Olivier and Taieb, Julien and ... and SARAH Trial Grp and SARAH Trial Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1624 - 1636
Sorafenib is the recommended treatment for patients with advanced hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of... 
SURVIVAL | THERAPY | ONCOLOGY | COMPETING RISK | TRANSARTERIAL CHEMOEMBOLIZATION | RADIOEMBOLIZATION | QUALITY-OF-LIFE | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Liver Neoplasms - mortality | Dose-Response Relationship, Drug | Microspheres | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Neoplasm Invasiveness - pathology | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Yttrium Radioisotopes - therapeutic use | Radiotherapy Dosage | Drug Administration Schedule | Administration, Oral | Brachytherapy - methods | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Niacinamide - adverse effects | Carcinoma, Hepatocellular - radiotherapy | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Liver Neoplasms - radiotherapy | Sorafenib | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged | Neoplasm Staging | Rare earth metals | Antimitotic agents | Product development | Hepatoma | Comparative analysis | Radiotherapy | Antineoplastic agents | Index Medicus | Life Sciences | Liver Neoplasms/drug therapy | Phenylurea Compounds/administration & dosage | Yttrium Radioisotopes/therapeutic use | Niacinamide/analogs & derivatives | Carcinoma, Hepatocellular/radiotherapy | Carcinoma, Hepatocellular/drug therapy | Cancer
Journal Article
Journal of Hepatology, ISSN 0168-8278, 08/2018, Volume 69, Issue 2, p. 555
Chalaye et al thank Noordzij et al. for their interest in their study "Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor... 
Liver cancer | Nuclear magnetic resonance--NMR | Magnetic resonance imaging | Computed tomography | Tomography | Hepatocellular carcinoma | Patients | Positron emission tomography | Tumors
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, pp. e0128353 - e0128353
Journal Article
HPB, ISSN 1365-182X, 06/2019, Volume 21, Issue 6, pp. 739 - 747
Background: This study assessed the prognostic value of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) in the... 
Journal Article
Gastroenterology, ISSN 0016-5085, 09/2019, Volume 157, Issue 3, pp. 807 - 822
In one-third of hepatocellular carcinomas (HCCs), cancer cells have mutations that activate β-catenin pathway. These cells have alterations in glutamine, bile,... 
CTNNB1 | Liver Cancer | Wnt Pathway | OCT3 | MOUSE-LIVER | ALPHA | TUMORS | METABOLISM | GENE | APC | F-18-FLUOROCHOLINE | PET/CT | LEADS | GASTROENTEROLOGY & HEPATOLOGY | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 03/2017, Volume 58, Issue 3, pp. 492 - 498
The aim of this study was to characterize brain metabolic abnormalities in patients with macrophagic myofascitis (MMF) and the relationship with cognitive... 
F-FDG PET | Brain | Neurology | Macrophagic myofascitis | Statistical parametric mapping | Aluminum hydroxide | PET/CT | Index Medicus
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 12/2014, Volume 55, Issue 12, pp. 2887 - 2892
Abstract This study evaluated the clinical impact of contrast-enhanced computed tomography (CECT) on routine management of patients with lymphoma. Over a... 
Contrast-enhanced CT | low-dose PET/CT | radiation exposure | patient management | lymphoma
Journal Article
Nuclear medicine and molecular imaging, ISSN 1869-3474, 09/2016, Volume 50, Issue 3, p. 258
A 67-year-old man was referred for fluctuating neuropsychiatric symptoms, featuring depression, delirious episodes, recurrent visual hallucinations and... 
Journal Article
Nuclear Medicine And Molecular Imaging, ISSN 1869-3474, 09/2016, Volume 50, Issue 3, p. 258
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s13139-016-0394-0 A... 
Antipsychotic drugs | PET imaging | Lewy body disease | Depression, Mental | SPECT imaging | Diagnosis | Alzheimer's disease
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.